Retraction of “miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway”
Weidong Zhou, Peifei Li, Peihua Jin
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related molecular mechanisms research · MicroRNA in disease regulation · Circular RNAs in diseases
Retraction of: Zhou W, Li P, Jin P. MiR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway. Open Medicine 2021;16(1):1683–1695, DOI: 10.1515/med-2021-0369
This article has been retracted by agreement between the Editor-in-Chief, Professor Vittorio Calabrese, and the publisher, Walter De Gruyter GMBH, following a thorough investigation. The retraction is due to misleading usage of the figures and undisclosed research outsourcing. Figures 2c, 2d, 2e, and 4b, 4c, 4d were wrongly included in the article and they are not connected to results. In addition, all presented experiments have been conducted by an unspecified external company, which raises questions about the integrity and rigor of the published research.